{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:34:15Z","timestamp":1789277655558,"version":"build-2803163510"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235326","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T13:28:13Z","timestamp":1594301293000},"page":"e0235326","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the\u00a0multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort"],"prefix":"10.1371","volume":"15","author":[{"given":"Paola","family":"Di Benedetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Daniela","family":"Grembiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-9638","authenticated-orcid":true,"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"pone.0235326.ref001","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/1744666X.2018.1533403","article-title":"Pathogenesis of adult onset still's disease: current understanding and new insights","volume":"14","author":"P Ruscitti","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0235326.ref002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"R Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"pone.0235326.ref003","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.","volume":"35","author":"P Sfriso","year":"2016","journal-title":"Clin Rheumatol."},{"key":"pone.0235326.ref004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still\u2019s disease. Clinical course and outcome","volume":"30","author":"JJ Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"pone.0235326.ref005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease.","volume":"13","author":"M Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev."},{"key":"pone.0235326.ref006","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s10067-017-3830-3","article-title":"Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.","volume":"36","author":"P Ruscitti","year":"2017","journal-title":"Clin Rheumatol"},{"key":"pone.0235326.ref007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/1744666X.2018.1465821","article-title":"Complications of adult-onset Still's disease and their management","volume":"14","author":"S Mitrovic","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0235326.ref008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","article-title":"Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers.","volume":"16","author":"P Ruscitti","year":"2017","journal-title":"Autoimmun Rev."},{"key":"pone.0235326.ref009","doi-asserted-by":"crossref","first-page":"e15123","DOI":"10.1097\/MD.0000000000015123","article-title":"Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study.","volume":"98","author":"P Ruscitti","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"pone.0235326.ref010","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"B Fautrel","year":"1999","journal-title":"J Rheumatol"},{"key":"pone.0235326.ref011","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"P Ruscitti","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0235326.ref012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","article-title":"Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.","volume":"33","author":"P Cipriani","year":"2014","journal-title":"Clin Rheumatol."},{"key":"pone.0235326.ref013","doi-asserted-by":"crossref","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","article-title":"Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.","volume":"94","author":"F Ortiz-Sanju\u00e1n","year":"2015","journal-title":"Medicine (Baltimore)."},{"key":"pone.0235326.ref014","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","article-title":"Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.","volume":"66","author":"F Ortiz-Sanju\u00e1n","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"pone.0235326.ref015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","article-title":"C-reactive protein and inflammation: conformational changes affect function","volume":"396","author":"Y Wu","year":"2015","journal-title":"Biol Chem"},{"key":"pone.0235326.ref016","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"W Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"pone.0235326.ref017","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease","volume":"28","author":"B Fautrel","year":"2001","journal-title":"J Rheumatol"},{"key":"pone.0235326.ref018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"C Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"pone.0235326.ref019","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.","volume":"14","author":"P Ruscitti","year":"2016","journal-title":"BMC Med."},{"key":"pone.0235326.ref020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","article-title":"Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.","volume":"21","author":"F Vercruysse","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"pone.0235326.ref021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","article-title":"Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies","volume":"41","author":"LJ Lesko","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"pone.0235326.ref022","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.","volume":"67","author":"M Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"pone.0235326.ref023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0009922819837352","article-title":"C-Reactive Protein and Ferritin Are Associated With Organ Dysfunction and Mortality in Hospitalized Children.","volume":"58","author":"CM Horvat","year":"2019","journal-title":"Clin Pediatr (Phila)."},{"key":"pone.0235326.ref024","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"M Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"pone.0235326.ref025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.170955","article-title":"Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort","volume":"45","author":"P Ruscitti","year":"2018","journal-title":"J Rheumatol"},{"key":"pone.0235326.ref026","article-title":"Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre \"real-life\" cohort.","author":"P Ruscitti","year":"2019","journal-title":"Rheumatol Int"},{"key":"pone.0235326.ref027","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients.","volume":"70","author":"J Pouchot","year":"1991","journal-title":"Medicine"},{"key":"pone.0235326.ref028","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still\u2019s disease.","volume":"33","author":"P Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"key":"pone.0235326.ref029","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.","volume":"66","author":"L Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"pone.0235326.ref030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases","volume":"46","author":"ED Batu","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"pone.0235326.ref031","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.","volume":"18","author":"JI Henter","year":"1991","journal-title":"Semin Oncol."},{"key":"pone.0235326.ref032","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"JI Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0235326.ref033","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"75","author":"A Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"pone.0235326.ref034","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.","volume":"13","author":"N Nirmala","year":"2015","journal-title":"Pediatr Rheumatol Online"},{"key":"pone.0235326.ref035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-014-2614-2","article-title":"Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature.","volume":"35","author":"A Cozzi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"pone.0235326.ref036","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"M Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"pone.0235326.ref037","doi-asserted-by":"crossref","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","article-title":"Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review","volume":"95","author":"M Gerfaud-Valentin","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"pone.0235326.ref038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrrheum.2013.14","article-title":"Mechanistic biomarkers for clinical decision making in rheumatic diseases.","volume":"9","author":"WH Robinson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"pone.0235326.ref039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"MA Knovich","year":"2009","journal-title":"Blood Rev"},{"key":"pone.0235326.ref040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.13057","article-title":"H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome","volume":"191","author":"P Ruscitti","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"pone.0235326.ref041","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/1744666X.2017.1372194","article-title":"Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?","volume":"13","author":"P Ruscitti","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0235326.ref042","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1378\/chest.123.6.2043","article-title":"C-reactive protein levels correlate with mortality and organ failure in critically ill patients.","volume":"123","author":"SM Lobo","year":"2003","journal-title":"Chest"},{"key":"pone.0235326.ref043","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00134-006-0509-7","article-title":"Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.","volume":"33","author":"C Rey","year":"2007","journal-title":"Intensive Care Med."},{"key":"pone.0235326.ref044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PCC.0000000000001029","article-title":"A Systemic Inflammation Mortality Risk Assessment Contingency Table for Severe Sepsis.","volume":"18","author":"JA Carcillo","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"pone.0235326.ref045","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.4049\/jimmunol.156.12.4815","article-title":"Expression of C-reactive protein by alveolar macrophages","volume":"156","author":"Q Dong","year":"1996","journal-title":"J Immunol"},{"key":"pone.0235326.ref046","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000441-200002000-00002","article-title":"Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue","volume":"319","author":"EE Diehl","year":"2000","journal-title":"Am J Med Sci"},{"key":"pone.0235326.ref047","first-page":"H507","article-title":"C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs","volume":"271","author":"VJ Abernathy","year":"1996","journal-title":"Am J Physiol"},{"key":"pone.0235326.ref048","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1357-4310(97)01145-3","article-title":"Role of C-reactive protein in acute lung injury","volume":"3","author":"RM Heuertz","year":"1997","journal-title":"Mol Med Today"},{"key":"pone.0235326.ref049","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/heartjnl-2014-306362","article-title":"Diagnosis and treatment of pericarditis","volume":"101","author":"M Imazio","year":"2015","journal-title":"Heart"},{"key":"pone.0235326.ref050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jelekin.2003.09.010","article-title":"Factors involved in strain-induced injury in skeletal muscles and outcomes of prolonged exposures.","volume":"14","author":"WT Stauber","year":"2004","journal-title":"J Electromyogr Kinesiol"},{"key":"pone.0235326.ref051","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s10194-017-0737-y","article-title":"Increased levels of intramuscular cytokines in patients with jaw muscle pain","volume":"18","author":"S Louca Jounger","year":"2017","journal-title":"J Headache Pain"},{"key":"pone.0235326.ref052","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2015.07.004","article-title":"Chronic fatigue syndrome and circulating cytokines: a systematic review","volume":"50","author":"S Blundell","year":"2015","journal-title":"Brain Behav Immun"},{"key":"pone.0235326.ref053","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"N Fall","year":"2007","journal-title":"Arthritis Rheum"},{"key":"pone.0235326.ref054","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"J Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"pone.0235326.ref055","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"EM Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"pone.0235326.ref056","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases\u2014evidence based analysis.","volume":"18","author":"R Giacomelli","year":"2019","journal-title":"Autoimmun Rev."},{"key":"pone.0235326.ref057","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","article-title":"International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.","volume":"16","author":"R Giacomelli","year":"2017","journal-title":"Autoimmun Rev."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:06:03Z","timestamp":1696352763000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235326"}},"subtitle":[],"editor":[{"given":"Massimo","family":"Cugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235326","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}